Log in to your Inderes Free account to see all free content on this page.
Subgen AI
0.07 SEK
+2.95 %
Less than 1K followers
SUBGEN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Subgen AI
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | 13.3 | 1.7 | 0.1 | 204.4 | ||
| growth-% | -87.1 % | -94.7 % | ||||
| EBITDA | -10.3 | -76.4 | -86.3 | -56.2 | -46.9 | -38.6 |
| EBIT | -10.3 | -80.2 | -86.3 | -56.2 | -46.9 | -69.2 |
| Profit before taxes | -10.3 | -92.7 | -85.5 | -61.2 | -51.5 | -90.0 |
| Net income | -10.3 | -92.3 | -84.0 | -59.7 | -50.0 | -88.9 |
| EPS | -74.39 | -663.83 | -569.87 | -313.96 | -160.94 | -0.08 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| EBITDA-% | -575.1 % | -5,044.4 % | -62,400.0 % | -18.9 % | ||
| EBIT-% | -603.5 % | -5,044.4 % | -62,400.0 % | -33.8 % | ||
| ROE | -22.1 % | -24.9 % | -26.4 % | 4,117.2 % | 129.3 % | -21.2 % |
| ROI | -19.9 % | -22.8 % | -24.4 % | -112.4 % | -153.2 % | -14.4 % |
Login required
This content is only available for logged in users